|
|||||
|
|
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity |
|
| Authors: | Nurit Omer MD Nir Giladi MD Tanya Gurevich MD Anat Bar-Shira PhD Mali Gana-Weisz PhD Tal Glinka MSc Orly Goldstein PhD Meir Kestenbaum MD Jesse M. Cedarbaum MD Omar S. Mabrouk PhD Kyle B. Fraser PhD Julia C. Shirvan MD PhD Avi Orr-Urtreger MD PhD Anat Mirelman PhD Avner Thaler MD PhD |
| Affiliation: | 1. Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel;2. Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel;3. Genetic Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel;4. Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel;5. Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel Neurology Department, Meir Medical Center, Kfar-Saba, Israel;6. Biogen Inc., Cambridge, Massachusetts, USA Coeruleus Clinical Sciences LLC, Woodbridge, Connecticut, USA;7. Biogen Inc., Cambridge, Massachusetts, USA;8. Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Medical Center, Tel-Aviv, Israel;9. Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel;10. Movement Disorders Unit, Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel |
| Abstract: | |
| Keywords: | Parkinson's disease LRRK2 GBA GCase |